FSH-blocking therapeutic for osteoporosis

Pharmacological and genetic studies over the past decade have established the follicle-stimulating hormone (FSH) as an actionable target for diseases affecting millions, namely osteoporosis, obesity, and Alzheimer’s disease. Blocking FSH action prevents bone loss, fat gain, and neurodegeneration in...

Descripción completa

Detalles Bibliográficos
Autores principales: Gera, Sakshi, Kuo, Tan-Chun, Gumerova, Anisa Azatovna, Korkmaz, Funda, Sant, Damini, DeMambro, Victoria, Sudha, Karthyayani, Padilla, Ashley, Prevot, Geoffrey, Munitz, Jazz, Teunissen, Abraham, van Leent, Mandy MT, Post, Tomas GJM, Fernandes, Jessica C, Netto, Jessica, Sultana, Farhath, Shelly, Eleanor, Rojekar, Satish, Kumar, Pushkar, Cullen, Liam, Chatterjee, Jiya, Pallapati, Anusha, Miyashita, Sari, Kannangara, Hasni, Bhongade, Megha, Sengupta, Puja, Ievleva, Kseniia, Muradova, Valeriia, Batista, Rogerio, Robinson, Cemre, Macdonald, Anne, Hutchison, Susan, Saxena, Mansi, Meseck, Marcia, Caminis, John, Iqbal, Jameel, New, Maria I, Ryu, Vitaly, Kim, Se-Min, Cao, Jay J, Zaidi, Neeha, Fayad, Zahi A, Lizneva, Daria, Rosen, Clifford J, Yuen, Tony, Zaidi, Mone
Formato: Online Artículo Texto
Lenguaje:English
Publicado: eLife Sciences Publications, Ltd 2022
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9550223/
https://www.ncbi.nlm.nih.gov/pubmed/36125123
http://dx.doi.org/10.7554/eLife.78022

Ejemplares similares

Ejemplares similares